The New Pharmaceutical Imperative With strong evidence suggesting systemic benefits far beyond glycemic control and weight managementincluding cardiovascular protection and effects on inflammationGLP-1s are now viewed as foundational longevity therapeutics
1) such as T2DM, cancer, cardiovascular disease (CVDs), and metabolic syndrome (MetS) [2]
A fund classified as non-diversified may invest a relatively high percentage of its assets in a limited number of issuers
Cancer 132 , 19861995 (2013)
GPX4-independent ferroptosisa new strategy in diseases therapy
For example, Calibrate Health offers members a year-long Intensive Lifestyle Intervention (ILI) programme, that combines coaching, online lessons, and tracking of various health behaviours